Browsing by Contributors Ribas, Antoni

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 13 of 13
PreviewIssue DateTitleContributor(s)
2016 AS Volume 264 Issue 4 October (2).pdf.jpg2016Cancer Research in the 21st CenturyEconomou, James S; Slamon, Dennis J; Ribas, Antoni; Phelps, Michael E
2011Defining the Critical Hurdles in Cancer ImmunotherapyFox, Bernard A; Schendel, Dolores J; Butterfield, Lisa H; Aamdal, Steinar; Allison, James P; Ascierto, Paolo Antonio; Atkins, Michael B; Bartunkova, Jirina; Bergmann, Lothar; Berinstein, Neil; Bonorino, Cristina C; Borden, Ernest; Bramson, Jonathan L; Britten, Cedrik M; Cao, Xuetao; Carson, William E; Chang, Alfred E; Characiejus, Dainius; Coukos, George; de Gruijl, Tanja; Dillman, Robert O; Dolstra, Harry; Durrant, Lindy G; Finke, James H; Galon, Jerome; Gollob, Jared A; Gouttefangeas, Cécile; Grizzi, Fabio; Guida, Michele; Håkansson, Leif; Hege, Kristen; Herberman, Ronald B; Hoos, Axel; Huber, Christoph; Hwu, Patrick; Imai, Kohzoh; Jaffee, Elizabeth M; Janetzki, Sylvia; June, Carl H; Kalinski, Pawel; Kaufman, Howard L; Kawakami, Koji; Kawakami, Yutaka; Keilholtz, Ulrich; Khleif, Samir N; Kiessling, Rolf; Kotlan, Beatrix; Kroemer, Guido; Lapointe, Rejean; Levitsky, Hyam I; Lotze, Michael T; Maccalli, Cristina; Maio, Michele; Marschner, Jens-Peter; Mastrangelo, Michael J; Masucci, Giuseppe; Melero, Ignacio; Melief, Cornelius; Nelson, Brad; Nicolini, Andrea; Nishimura, Michael I; Odunsi, Kunle; Ohashi, Pamela S; O'Donnell-Tormey, Jill; Old, Lloyd J; Ottensmeier, Christian; Papamichail, Michael; Parmiani, Giorgio; Pawelec, Graham; Proietti, Enrico; Qin, Shukui; Rees, Robert; Ribas, Antoni; Ridolfi, Ruggero; Ritter, Gerd; Rivoltini, Licia; Romero, Pedro J; Salem, Mohamed L; Scheper, Rik J; Seliger, Barbara; Sharma, Padmanee; Shiku, Hiroshi; Singh-Jasuja, Harpreet; Song, Wenru; Straten, Per Thor; Tahara, Hideaki; Tian, Zhigang; van Der Burg, Sjoerd H; von Hoegen, Paul; Wang, Ena; Welters, Marij JP; Winter, Hauke; Withington, Tara; Wolchok, Jedd D; Xiao, Weihua; Zitvogel, Laurence; Zwierzina, Heinz; Marincola, Francesco M; Gajewski, Thomas F; Wigginton, Jon M; Disis, Mary L; Choudhury, A. Raja; Dranoff, Glenn; Hodi, Frank Stephen; Murphy, William J.
2010Differential Sensitivity of Melanoma Cell Lines with BRAFV600E Mutation to the Specific Raf Inhibitor PLX4032Søndergaard, Jonas N; Nazarian, Ramin; Guo, Deliang; Hsueh, Teli; Mok, Stephen; Sazegar, Hooman; Barretina, Jordi G; Kehoe, Sarah M; Attar, Narsis; von Euw, Erika; Zuckerman, Jonathan E; Chmielowski, Bartosz; Comin-Anduix, Begoña; Koya, Richard C; Mischel, Paul S; Lo, Roger S; Ribas, Antoni; Wang, Qi; MacConaill, Laura Eleanor
JoCO 2018 Volume 36 Issue 17 June (3).pdf.jpg2018Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic MelanomaRobert, Caroline; Ribas, Antoni; Hamid, Omid; Daud, Adil; Wolchok, Jedd D; Joshua, Anthony M; Hwu, Wen-jen; Weber, Jeffrey S; Gangadhar, Tara C; Joseph, Richard W; Dronca, Roxana; Patnaik, Amita; Zarour, Hassane; Hersey, Peter; Zhang, Jin; Anderson, James; Diede, Scott J
2016 JCO Volume 34 Issue 13 May (6).pdf.jpg2016Evaluation of Immune-Related Response Criteria and RECIST v1 . 1 in Patients With Advanced Melanoma Treated With PembrolizumabHodi, F Stephen; Hwu, Wen-jen; Kefford, Richard; Weber, Jeffrey S; Daud, Adil; Hamid, Omid; Patnaik, Amita; Ribas, Antoni; Robert, Caroline; Gangadhar, Tara C; Joshua, Anthony M; Hersey, Peter; Dronca, Roxana; Joseph, Richard; Hille, Darcy; Xue, Dahai; Li, Xiaoyun Nicole
2013Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012”Ascierto, Paolo A; Grimaldi, Antonio M; Acquavella, Nicolas; Borgognoni, Lorenzo; Calabrò, Luana; Cascinelli, Natale; Cesano, Alessandra; Del Vecchio, Michele; Eggermont, Alexander M; Faries, Mark; Ferrone, Soldano; Fox, Bernard A; Gajewski, Thomas F; Galon, Jérôme; Gnjatic, Sacha; Gogas, Helen; Kashani-Sabet, Mohammed; Kaufman, Howard L; Larkin, James; Lo, Roger S; Mantovani, Alberto; Margolin, Kim; Melief, Cornelis; McArthur, Grant; Palmieri, Giuseppe; Puzanov, Igor; Ribas, Antoni; Seliger, Barbara; Sosman, Jeff; Suenaert, Peter; Tarhini, Ahmad A; Trinchieri, Giorgio; Vidal-Vanaclocha, Fernando; Wang, Ena; Ciliberto, Gennaro; Mozzillo, Nicola; Marincola, Francesco M; Thurin, Magdalena
2014Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”, Napoli, December 5th-8th 2013Ascierto, Paolo A; Grimaldi, Antonio M; Anderson, Ana Carrizosa; Bifulco, Carlo; Cochran, Alistair; Garbe, Claus; Eggermont, Alexander M; Faries, Mark; Ferrone, Soldano; Gershenwald, Jeffrey E; Gajewski, Thomas F; Halaban, Ruth; Hodi, F Stephen; Kefford, Richard; Kirkwood, John M; Larkin, James; Leachman, Sancy; Maio, Michele; Marais, Richard; Masucci, Giuseppe; Melero, Ignacio; Palmieri, Giuseppe; Puzanov, Igor; Ribas, Antoni; Saenger, Yvonne; Schilling, Bastian; Seliger, Barbara; Stroncek, David; Sullivan, Ryan; Testori, Alessandro; Wang, Ena; Ciliberto, Gennaro; Mozzillo, Nicola; Marincola, Francesco M; Thurin, Magdalena
30.pdf.jpg1-Jan-2015Improved overall survival in melanoma with combined dabrafenib and trametinibRobert, Caroline; Karaszewska, Boguslawa; Schachter, Jacob; Rutkowski, Piotr; Mackiewicz, Andrzej; Stroiakovski, Daniil; Lichinitser, Michael; Dummer, Reinhard; Grange, Florent; Mortier, Laurent; Chiarion-Sileni, Vanna; Drucis, Kamil; Krajsova, Ivana; Hauschild, Axel; Lorigan, Paul; Wolter, Pascal; Long, Georgina V; Flaherty, Keith; Nathan, Paul; Ribas, Antoni; Martin, Anne-Marie; Sun, Peng; Crist, Wendy; Legos, Jeff; Rubin, Stephen D; Little, Shonda M; Schadendorf, Dirk
2017 Lancet Volume 390 Issue 10105 October (1).pdf.jpg2017Pembrolizumab versus ipilimumab for advanced melanoma : final overall survival results of a multicentre , randomised , open-label phase 3 study ( KEYNOTE-006 )Schachter, Jacob; Ribas, Antoni; Long, Georgina V; Arance, Ana; Grob, Jean-jacques; Mortier, Laurent; Daud, Adil; Carlino, Matteo S; Mcneil, Catriona; Lotem, Michal; Larkin, James; Lorigan, Paul; Neyns, Bart; Blank, Christian; Petrella, Teresa M; Hamid, Omid; Zhou, Hongh
2521.pdf.jpg25-Jun-2015Pembrolizumab versus Ipilimumab in Advanced MelanomaRobert, Caroline; Schachter, Jacob; Long, Georgina V; Arance, Ana; Grob, Jean Jacques; Mortier, Laurent; Daud, Adil; Carlino, Matteo S; McNeil, Catriona; Lotem, Michal; Larkin, James; Lorigan, Paul; Neyns, Bart; Blank, Christian U; Hamid, Omid; Mateus, Christine; Shapira-Frommer, Ronnie; Kosh, Michele; Zhou, Honghong; Ibrahim, Nageatte; Ebbinghaus, Scot; Ribas, Antoni
2016 JCO Volume 34 Issue 34 December (24).pdf.jpg2016Programmed Death-Ligand 1 Expression and Response to the Anti – Programmed Death 1 Antibody Pembrolizumab in MelanomaDaud, Adil I; Wolchok, Jedd D; Robert, Caroline; Hwu, Wen-jen; Weber, Jeffrey S; Ribas, Antoni; Hodi, F Stephen; Joshua, Anthony M; Kefford, Richard; Hersey, Peter; Joseph, Richard; Gangadhar, Tara C; Dronca, Roxana; Patnaik, Amita; Zarour, Hassane; Roach, Charlotte; Tol
2012Tumor microenvironment induces innate RAF-inhibitor resistance through HGF secretionStraussman, Ravid; Morikawa, Teppei; Shee, Kevin; Barzily-Rokni, Michal; Qian, Zhi Rong; Du, Jinyan; Davis, Ashli; Mongare, Margaret M.; Gould, Joshua; Frederick, Dennie T.; Cooper, Zachary A.; Chapman, Paul B.; Solit, David B.; Ribas, Antoni; Lo, Roger S.; Flaherty, Keith T.; Ogino, Shuji; Wargo, Jennifer A.; Golub, Todd R.
2012Tumor microenvironment induces innate RAF-inhibitor resistance through HGF secretionStraussman, Ravid; Morikawa, Teppei; Shee, Kevin; Barzily-Rokni, Michal; Qian, Zhi Rong; Du, Jinyan; Davis, Ashli; Mongare, Margaret M.; Gould, Joshua; Frederick, Dennie T.; Cooper, Zachary A.; Chapman, Paul B.; Solit, David B.; Ribas, Antoni; Lo, Roger S.; Flaherty, Keith T.; Ogino, Shuji; Wargo, Jennifer A.; Golub, Todd R.